Follicular adenoma with papillary architecture: A lesion mimicking papillary thyroid carcinoma

Histopathology

Volumn 39, Issue 1, 2001, Pages 25-32

  Mai, K T ^a,b   Landry, D C ^b   Thomas, J ^a,b   Burns, B F ^a,b   Commons, A S ^a,b   Yazdi, H M ^a,b   Odell, P F ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cytokeratin 19; Follicular adenoma; HBME; Papillary thyroid carcinoma

Indexed keywords

ONCOPROTEIN;

ADENOMA; ADULT; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; ENCAPSULATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR CELL;

ADENOMA; ADULT; ANTIGENS, NUCLEAR; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034850810     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2001.01148.x     Document Type: Article

References (50)

1. Papillary carcinoma
2. Thyroid papillary carcinoma. Pathological and philosophical controversies
3. Is the differentiation between papillary and follicular thyroid carcinoma valid?
4. Well differentiated thyroid carcinoma
5. Papillary carcinoma of the thyroid. A discussion of its several morphologic expressions, with particular emphasis on the follicular variant
6. Histogenesis of thyroid carcinoma
7. The demise of follicular carcinoma of the thyroid gland
8. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms
9. Papillary lesion of the thyroid, chapter 8
10. The significance of nuclear changes in papillary thyroid carcinomas and papillary thyroid carcinoma-related neoplastic lesions
11. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules
12. Papillary thyroid carcinoma and related thyroid neoplastic lesions: A light microscopic study with emphasis on nuclear changes
13. Worrisome histologic alterations following fine needle aspiration of the thyroid (WHAFF)
14. Prognostic importance of histologic grading in papillary thyroid carcinoma
15. Infiltrating papillary thyroid carcinoma: Review of 134 cases of papillary carcinoma
16. Prognostic value of morphometry in papillary thyroid carcinoma
17. The significance of nuclear diameter in the biologic behavior of thyroid carcinomas: A retrospective study of 127 cases
18. Optically clear and vacuolated nuclei. Two useful signs for the transoperative diagnosis of papillary carcinoma of the thyroid
19. The grooved nucleus. A useful diagnostic criterion of papillary carcinoma of the thyroid
20. Studies on intranuclear inclusions and nuclear grooves in papillary thyroid cancer by light, scanning electron and transmission electron microscopy
21. Clonal analysis of a solitary follicular nodule of the thyroid with the polymerase chain reaction method
22. Follicular lesions of the thyroid
23. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors
24. Brief report: Detection of high-molecular-weight cytokeratins in neoplastic and non-neoplastic thyroid tumors using microwave antigen retrieval
25. Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies
26. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications
27. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma
28. Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins
29. Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules
30. HBME-1 immunostaining in thyroid fine-needle aspirations: A useful marker in the diagnosis of carcinoma
31. Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours
32. An immunohistochemical study of epithelial membrane antigen, cytokeratin, and vimentin in papillary thyroid carcinoma. Recognition of lethal and favorable prognostic types
33. The RET gene in thyroid pathology
34. RET proto-oncogene in the development of human cancer
35. Different mutations of the RET gene cause different human tumoral diseases
36. Altered expression of RET proto-oncogene product in prostatic intraepithelial neoplasia and prostate cancer
37. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure
38. RET/PTC oncogene activation is an early event in thyroid carcinogenesis
39. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation
40. Gene rearrangement and Chernobyl related thyroid cancers
41. The RET/PTC3 oncogene: Metastatic solid-type papillary carcinomas in murine thyroids
42. High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: A strong correlation between RET/PTC3 and the solid-follicular variant
43. Preferential induction of RET/PTC1 rearrangement by X-ray irradiation
44. Expression of wild-type ret, ret/PTC and ret/PTC variants in papillary thyroid carcinoma in Germany
45. Distinct multiple RET/PTC gene rearrangements in multifocal papillary thyroid neoplasia
46. Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?
47. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas
48. Ret oncogene activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters
49. High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas
50. High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiation